Evidence map›Paper›PMID 36362286›Full record

ArticleInternational journal of molecular sciences2022

Topical Administration of a Novel Acetylated Tetrapeptide Suppresses Vascular Permeability and Immune Responses and Alleviates Atopic Dermatitis in a Murine Model.

Bokyung Sung, Yi-Yong Baek, Young-Myeong Kim, Ji Chang You

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bokyung SungAvixgen Inc., 2477, Nambusunhwan-ro, Seocho-gu, Seoul 06725, Korea.
Yi-Yong BaekAvixgen Inc., 2477, Nambusunhwan-ro, Seocho-gu, Seoul 06725, Korea.
Young-Myeong KimDepartment of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chuncheon 24341, Korea.ORCID 0000-0002-8326-7768
Ji Chang YouAvixgen Inc., 2477, Nambusunhwan-ro, Seocho-gu, Seoul 06725, Korea.
Avixgen (South Korea) · KRKangwon National University · KR

Funding

National Research Foundation of Korea 2017R1A5A1015366National Research Foundation of Korea 2020R1F1A1075725
6 · The paper itself

Abstract

Although the pathogenesis of atopic dermatitis (AD) remains to be fully deciphered, skin barrier abnormality and immune dysregulation are known to be involved. Recently, the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) system has also been implicated in the pathogenesis of this multifactorial chronic inflammatory skin disorder. Previously, we showed that a novel tetrapeptide,

Indexed as

Dermatitis, AtopicAdministration, TopicalAnimalsCapillary PermeabilityCytokinesDisease Models, AnimalEndothelial CellsImmunityMiceSkinVascular Endothelial Growth Factor ACytokinesVascular Endothelial Growth Factor AAc-RLYEatopic dermatitiscytokinesinflammationvascular permeability

Identifiers

PMID36362286
PMCPMC9658216
OpenAlexW4308333340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.